Patents Assigned to Engimata, Inc.
  • Patent number: 11559577
    Abstract: An immunogenic composition forming a vaccine includes a nanoparticle delivery system comprising at least a nanoparticle, wherein the at least a nanoparticle comprises a lipid layer exterior including a plurality of lipids, cholesterol, and a primary alkyl amine including a positively charged amino group head and at least a carbon tail and an antigen incorporated in the at least a nanoparticle, wherein the antigen comprises a nucleic acid encoding a protein from a coronavirus.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: January 24, 2023
    Assignee: Engimata, Inc.
    Inventors: Mitra Mosharraf, Aryo Sorayya, Rajiv Nayar
  • Publication number: 20210299244
    Abstract: An immunogenic composition forming a vaccine includes a nanoparticle delivery system comprising at least a nanoparticle, wherein the at least a nanoparticle comprises a lipid layer exterior including a plurality of lipids, cholesterol, and a primary alkyl amine including a positively charged amino group head and at least a carbon tail and an antigen incorporated in the at least a nanoparticle, wherein the antigen comprises a nucleic acid encoding a protein from a coronavirus.
    Type: Application
    Filed: March 17, 2021
    Publication date: September 30, 2021
    Applicant: Engimata, Inc.
    Inventors: Mitra Mosharraf, Aryo Sorayya, Rajiv Nayar